Recruiting
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
NCT07425639
- Conditions
- Allergic Asthma, Chronic Disease, Chronic Spontaneous Urticaria (CSU), +11 more
- Locations
-
- CHU Montpellier Montpellier, France